Psychedelic-assisted therapy for mental health: Policy considerations
Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.

This POSTnote outlines current drug pricing policy and examines other options to evaluate pricing, including "value-based" pricing.
Drug pricing, October 2010 (368 KB , PDF)
Drug pricing, October 2010 (368 KB , PDF)
Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.
New parliamentary research project approved to explore the impacts of birthrate decline
This POSTnote summarises the ethical implications and regulatory considerations for deploying Artificial Intelligence (AI) in mental healthcare.